SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092778
Filing Date
2024-08-07
Accepted
2024-08-07 16:10:15
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20240630.htm   iXBRL 10-Q 1557034
2 EX-31.1 tyra-ex31_1.htm EX-31.1 16450
3 EX-31.2 tyra-ex31_2.htm EX-31.2 16629
4 EX-32.1 tyra-ex32_1.htm EX-32.1 8995
5 EX-32.2 tyra-ex32_2.htm EX-32.2 8958
  Complete submission text file 0000950170-24-092778.txt   6864689

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20240630.xsd EX-101.SCH 952645
65 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20240630_htm.xml XML 1323437
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 241183755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)